On Fraud | GenomeWeb

On Fraud

The Wall Street Journal's Health Blog speaks with John Dahlberg, who is the director of the Division of Investigative Oversight in the Office of Research Integrity at HHS, about scientific fraud. Dahlberg says that fraud cases are rare and when they do occur it's often a grad student or a postdoc succumbing to pressure, either from a PI or self-imposed. If the damage is serious, Dahlberg says "we'll recommend voluntary exclusion. It's like a disbarment.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.